Cochlear Limited (OTCMKTS:CHEOY) is a global medical device company specializing in implantable hearing solutions. Headquartered in Sydney, Australia, Cochlear has been at the forefront of auditory technology since its founding in 1981, when the company developed one of the world’s first multi-channel cochlear implants. Over the decades, Cochlear has expanded its product portfolio to include bone conduction systems and acoustic implants, helping to restore hearing for individuals across a broad spectrum of hearing loss conditions.
The company’s core offerings include cochlear implants designed to convert sound into electrical impulses that directly stimulate the auditory nerve, and bone conduction devices that transmit sound through cranial bones for patients with conductive hearing impairment. In addition to its implantable devices, Cochlear provides a suite of sound processors, wireless accessories, and proprietary software platforms that enable clinicians to map and fine-tune hearing solutions to each patient’s unique needs. Comprehensive audiological and surgical training programs complement these products, ensuring best practices in implantation and ongoing care.
With operations spanning North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa, Cochlear serves more than 100 markets through a network of subsidiaries and distribution partners. The company maintains research and development centers in key regions, collaborating with universities, hospitals and hearing health professionals to drive innovation. Local service teams support thousands of surgeons and audiologists worldwide, offering technical assistance, rehabilitation resources and peer-to-peer forums.
Leadership at Cochlear is headed by Managing Director and Chief Executive Officer Dig Howitt, who brings more than two decades of experience in the global medical technology sector. Under his guidance, Cochlear continues to invest heavily in R&D and clinical studies, while upholding its mission to help people with hearing loss connect with the world. The company also operates the Cochlear Foundation, a philanthropic arm dedicated to education, research funding and community outreach in hearing health.
AI Generated. May Contain Errors.
Free CHEOY Stock Alerts